Joseph Minkowitz
Coffee, Cannabis, Psychedelics, and Clinical Trials
What if the future of health optimization isn't hiding in the next trend, but inside clinical trials happening right now?
In this episode of The Better Body Lab Podcast, we sit down with clinical trial recruitment expert and founder of Patients VIP, Joseph Minkowitz, to explore the remarkable world of medical research and the discoveries quietly reshaping the future of human health. Together, we examine how resilience, recovery, longevity, and performance are increasingly influenced by innovations that most people never hear about until years after they become available.
From psychedelics and personalized cancer vaccines to breakthroughs in Type 1 diabetes, chronic pain, hearing restoration, and regenerative medicine, our conversation offers a rare glimpse into the front lines of clinical research. We also explore the uncomfortable reality that nearly 90% of potential therapies never make it from laboratory concept to human clinical trials, and why that makes the breakthroughs that do emerge all the more remarkable.
As consumers navigate a rapidly evolving health landscape filled with headlines, social media claims, and emerging therapies, this episode asks an important question: how do we distinguish scientific progress from optimism, and hype from evidence?
Episode Overview
Together, we explore how science and lived experience intersect within the human ecology of health, the dynamic relationship between biology, environment, behavior, and medical innovation.
Joseph shares his journey from digital marketing and patient recruitment into becoming one of social media's leading translators of complex medical research through his platform, The Studies Guy. Along the way, we discuss why clinical trials matter, how new therapies move through the approval process, and why patient participation may be one of the most overlooked contributions to medical progress.
Our conversation spans some of the most exciting developments currently occurring in medicine: the role of caffeine in cognitive resilience, the relationship between alcohol and dementia risk, emerging psychedelic therapies for depression, gene therapy breakthroughs for hearing loss, personalized cancer vaccines, and regenerative treatments that may one day restore damaged cartilage and reverse chronic disease.
This episode ultimately reinforces a powerful truth: innovation changes lives, but only when science, rigor, and accessibility work together.
What You’ll Learn in This Episode
• Why nearly 90% of drug candidates never reach human clinical trials
• How clinical trials move from animal studies to FDA approval
• What research suggests about coffee consumption and dementia risk
• Why alcohol may be one of the largest modifiable risk factors for cognitive decline
• The latest breakthroughs in Type 1 diabetes treatment and islet cell transplantation
• How researchers may have identified a neurological "switch" for chronic pain
• The growing role of psychedelics in depression and mental health treatment
• How gene therapy is restoring hearing in patients born deaf
• Why personalized mRNA vaccines may transform pancreatic cancer treatment
• The science behind emerging regenerative therapies for osteoarthritis and cartilage repair
• The hidden benefits of participating in clinical trials
• How consumers can become better evaluators of health research and medical headlines
About Our Guest
Joseph Minkowitz is the founder of Patients VIP, a company specializing in patient recruitment for clinical trials. He got his start at Vanderbilt, learning digital marketing hands-on under one of the top practitioners in the field during the day, and spending his nights in the library teaching himself everything else. He put those skills to work helping his family's research site and other practices find patients, then went on to serve as a Marketing Director at a venture capital group before launching Patients VIP. Today, Patients VIP is trusted by over 45 sponsors and CROs across multiple therapeutic areas, having recruited for hundreds of studies across over 100 sites in over 5 countries. Joseph’s exposure to various studies sparked his social media channels, @TheStudiesGuy, where he has built an audience of over 250,000 people by breaking down cutting-edge clinical research for everyday audiences.
For information about Patients VIP visit: https://patients.vip/ and https://thestudiesguy.com/
Follow Joseph Minkowitzhere:
Instagram: @TheStudiesGuy
Facebook: @TheStudiesGuy
LinkedIn: https://www.linkedin.com/in/joseph-minkowitz-b9b9aa48/
